1997
DOI: 10.1016/s1090-820x(97)80060-x
|View full text |Cite
|
Sign up to set email alerts
|

Factors contributing to adverse effects of the tumescent technique*

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

1998
1998
2015
2015

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 14 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…This induces significant changes in fluid behaviour inside the compartment, with the risk of pulmonary oedema and heart failure. 2 Added to the invention by Klein in 1987 of a tumescent solution that included 500-1000 mg of lidocaine plus 1 mg of epinephrine for every 1000 cc of NSS 3 (Fig. 1) and which is widely used today for subcutaneous infiltration, the risk of lidocaine toxicity is a reality and the second cause of death in plastic surgery according to the American Society of Plastic Surgeons (ASPS).…”
Section: Introductionmentioning
confidence: 99%
“…This induces significant changes in fluid behaviour inside the compartment, with the risk of pulmonary oedema and heart failure. 2 Added to the invention by Klein in 1987 of a tumescent solution that included 500-1000 mg of lidocaine plus 1 mg of epinephrine for every 1000 cc of NSS 3 (Fig. 1) and which is widely used today for subcutaneous infiltration, the risk of lidocaine toxicity is a reality and the second cause of death in plastic surgery according to the American Society of Plastic Surgeons (ASPS).…”
Section: Introductionmentioning
confidence: 99%
“…Since most of the infiltrate, ranging from 22-29 percent, is not removed by suctioning, at least 70 percent of the infiltrate is believed to remain after the procedure 20,49 . Fluid overload 28,33,41,[51][52][53] becomes possible whenever substantial amounts of tumescent infiltrative fluids or parenteral fluids are used in high volume cases with the tumescent (3-4:1 ratio) and superwet (1-1.5:1) techniques. Since WAL's variable force infusion pump pulses fan-shaped jets of tumescent solution into the subcutaneous fatty tissue during its three procedural phases, but only suctions simultaneously the loosened fat and fluid during the latter two phases, the final physiological and pharmacological impact is expected to reflect more closely the infiltrationto-aspiration ratios (between 3-4:1) observed with the tumescent technique.…”
mentioning
confidence: 99%